Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey

No Thumbnail Available
Authors
Monk, B. J.
Lammers, P. E.
Cartwright, T.
Jacobs, I.
Issue Date
2017
Type
Journal Article
Language
Keywords
Research Projects
Organizational Units
Journal Issue
Alternative Title
Abstract
Description
Citation
Monk, B. J.; Lammers, P. E.; Cartwright, T.; Jacobs, I. (2017). Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey. Pharmaceuticals (Basel), January 2017, 10(1):(11 pages). doi: http://dx.doi.org/10.3390/ph10010019
Publisher
License
Journal
Volume
Issue
PubMed ID
DOI
ISSN
1424-8247
EISSN